Last Friday we highlighted BYD Company (OTCMKTS: BYDDF) as a buying opportunity as it traded around $6 a share. Our timing could not have been better: a day later, the vice minister of China’s Ministry of Industry and Information Technology stated that the Chinese government is working on a timetable… Read More
Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.
Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.
Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.
BYD Company (OTCMKTS: BYDDF) briefly fell below $6 per share earlier this week before rebounding a bit. Since reaching a 3-month peak in late July, the shares have been under some pressure. Let’s take a look at how the company is faring. In the first half of 2017, BYD had… Read More
Parents in China are spending an increasing amount of money on tutoring to try to give their kids an edge in the highly competitive race to enter the best universities. Many students begin to prepare for the college entrance exam in elementary school. The explosive demand has created tremendous opportunity for tutoring operators. Read More
Our three new picks this month got off to a bit of a slow start, but they have all recovered very nicely. What’s more, due to the stocks’ price action, most of our readers probably were able to buy shares of these new recommendations at better entry prices than we… Read More
Sell Theravance Biopharma (Nasdaq: TBPH), Franco-Nevada (NYSE: FNV), and USG Corp (NYSE: USG). We recommend taking gains on Theravance Biopharma (Nasdaq: TBPH) and Franco-Nevada (NYSE: FNV), both of which have had nice recent runs. We may revisit these stocks in the future if the opportunity is right. Hurricane Harvey has… Read More
A Chinese online gaming stock has fallen sharply since reporting quarterly results that did not match the previous quarter's blowout numbers. We think the slowdown in mobile-game growth is temporary and the acceleration of growth in its ecommerce business bodes well for a rebound. Read More
We have had good success following Chase Coleman III’s Tiger Global in the past and this week, we again added a top holding from the hedge fund to our portfolio: TAL Education (NYSE: TAL), a leading operator in a booming industry in China: private tutoring. In China, the job market… Read More
Our S&P indicator has continued from its already positive reading. In fact the last time the weekly indicator was as high as today was toward the beginning of 2016, which was a very good time to be in stocks. A further decline in the VIX Index would slightly weaken the… Read More
Buy TAL Education Group (NYSE: TAL) Tiger Global Management owns 9.85 million shares, or about 3.5 percent of the U.S.-traded ADRs of this leading tutorial center operator in China which focuses on high-achieving students in the K to 12 curriculum. A culture that places heavy emphasis on education, the Chinese… Read More
Although Apple (Nasdaq: AAPL) is already, by far, the world's largest company by market cap, it has consistently proven that with one great product, it can still grow. A company trading at a very reasonable valuation, AAPL offers a high floor and we think it is a must-own for investors. Read More